Search Details

Word: claritin (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

What doesn't make sense is that one of Gore's senior advisers, top-tier lobbyist Peter Knight, is a hired gun for pharmaceuticals giant Schering-Plough, which is in a red-hot battle to stretch out its patent for the best-selling allergy medication Claritin beyond 2002. The New Jersey-based company paid Knight's firm $100,000 in the first half of this year alone...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

...course, Schering-Plough would pay almost any amount of money to protect its exclusive right to sell Claritin, a drug that brings it more than $5 million in revenue a day. Claritin sales totaled $1.9 billion last year, and will balloon to $4 billion by 2002, according to a market analyst. To keep the money coming in, the company doubled its lobbying outlay starting in 1996 to more than $4 million in 1998. Among its other paid advocates: former Senator Dennis DeConcini; former Watergate assistant special prosecutor Richard Ben-Veniste; and Thomas Parry, former chief of staff for Senator Orrin...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

Schering-Plough argues that additional patent years are only fair. Claritin was stuck in the Food and Drug Administration approval pipeline longer than many drugs, it claims, with the clock ticking on its 17-year patent. Schering-Plough also says Claritin profits help fund research for new drugs. But, its opponents counter, what about Claritin patients--who pay as much as $2.66 a dose instead of the 50[cents] or less they would pay, analysts figure, if a generic version of the drug were available? If the patent expires on time, according to a University of Minnesota study funded...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

...moving the bill. Knight says he is closing down his firm to spend more time on the Gore campaign. But Schering-Plough is expected to continue the battle next year. If it loses again, the company has that contingency covered too: the FDA is currently considering its new super-Claritin for market approval. Its patent wouldn't expire until...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

Legal Seafood, Nantucket Nectars and Claritin were among the vendors at the regatta...

Author: By Robert B. Davis, CONTRIBUTING WRITER | Title: Crowds Flock to Head Of the Charles Regatta | 10/19/1998 | See Source »

| 1 | 2 | 3 | 4 | Next